NO20031204L - Fremgangsmate for billedmessig presentasjon og diagnose av tromber ved hjelp av kjernespinntomografi under anvendelse av partikulaere kontrastmidler - Google Patents

Fremgangsmate for billedmessig presentasjon og diagnose av tromber ved hjelp av kjernespinntomografi under anvendelse av partikulaere kontrastmidler

Info

Publication number
NO20031204L
NO20031204L NO20031204A NO20031204A NO20031204L NO 20031204 L NO20031204 L NO 20031204L NO 20031204 A NO20031204 A NO 20031204A NO 20031204 A NO20031204 A NO 20031204A NO 20031204 L NO20031204 L NO 20031204L
Authority
NO
Norway
Prior art keywords
thrombus
diagnosis
imaging
procedures
contrast agents
Prior art date
Application number
NO20031204A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031204D0 (no
Inventor
Stephan Schmitz
Mayk Kresse
Susanne Wagner
Original Assignee
Diagnostikforschung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst filed Critical Diagnostikforschung Inst
Publication of NO20031204L publication Critical patent/NO20031204L/no
Publication of NO20031204D0 publication Critical patent/NO20031204D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0263—Measuring blood flow using NMR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026—Measuring blood flow
    • A61B5/0275—Measuring blood flow using tracers, e.g. dye dilution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Signal Processing (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Epidemiology (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20031204A 2000-09-15 2003-03-17 Fremgangsmåte for billedmessig presentasjon og diagnose av tromber ved hjelp av kjernespinntomografi under anvendelse av partikul¶rekontrastmidler NO20031204D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10046514A DE10046514A1 (de) 2000-09-15 2000-09-15 Verfahren zur bildlichen Darstellung und Diagnose von Thromben mittels Kernspintomographie unter Verwendung partikulärer Kontrastmittel
PCT/EP2001/010233 WO2002022011A1 (de) 2000-09-15 2001-09-05 Verfahren zur bildlichen darstellung und diagnose von thromben mittels kernspintomographie unter verwendung partikulärer kontrastmittel

Publications (2)

Publication Number Publication Date
NO20031204L true NO20031204L (no) 2003-03-17
NO20031204D0 NO20031204D0 (no) 2003-03-17

Family

ID=7656910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031204A NO20031204D0 (no) 2000-09-15 2003-03-17 Fremgangsmåte for billedmessig presentasjon og diagnose av tromber ved hjelp av kjernespinntomografi under anvendelse av partikul¶rekontrastmidler

Country Status (7)

Country Link
EP (1) EP1317208A1 (de)
JP (1) JP2004508123A (de)
AU (1) AU2002212207A1 (de)
DE (1) DE10046514A1 (de)
NO (1) NO20031204D0 (de)
TW (1) TWI239830B (de)
WO (1) WO2002022011A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10222481A1 (de) * 2002-05-22 2003-12-04 Eucro Europe Contract Res Gmbh Kontrastmittel für die Verwendung in bildgebenden Verfahren
FR2861994A1 (fr) * 2003-11-12 2005-05-13 Guerbet Sa Nouvel agent de diagnostic pour l'irm dans les pathologies impliquant des proteinases
GB2439747A (en) * 2006-07-03 2008-01-09 Uni Degli Studi Di Urbino Carl Delivery of contrasting agents for magnetic resonance imaging
EP2732046B1 (de) * 2011-07-13 2017-09-06 T2 Biosystems, Inc. Kernspinresonanzverfahren zur überwachung der bildung von blutgerinnseln
EP3087921A1 (de) 2015-04-27 2016-11-02 Coronary Technologies SARL Computerimplementiertes verfahren zur identifizierung von zonen mit stase und stenose in blutgefässen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007408D0 (en) * 1990-04-02 1990-05-30 Nycomed As Compositions
US5766572A (en) * 1992-08-05 1998-06-16 Meito Sangyo Kabushiki Kaisha Water-soluble carboxypolysaccharide-magnetic iron oxide complex having a small particle diameter
GB9401483D0 (en) 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds
DE19509694A1 (de) * 1995-03-08 1996-09-19 Schering Ag Verwendung von Magnetiten zur Bestimmung der Perfusion von menschlichem Gewebe mittels MR-Diagnostik
CN1151846C (zh) 1996-08-05 2004-06-02 舍林公开股份有限公司 核磁共振断层扫描成像用造影剂的制备方法
AU4753997A (en) 1996-10-16 1998-05-11 Burnham Institute, The Magnetic resonance imaging of thrombi
DE19811349C1 (de) * 1998-03-16 1999-10-07 Siemens Ag Verfahren zur Kontrastmittelverfolgung mittels eines bildgebenden medizinischen Geräts und Steuervorrichtung zur Durchführung des Verfahrens
JP5064612B2 (ja) * 1999-04-09 2012-10-31 エーエムエージー ファーマシューティカルズ，インコーポレイテッド 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄
AU5085800A (en) * 1999-05-21 2000-12-12 Nycomed Imaging As Method of magnetic resonance imaging

Also Published As

Publication number Publication date
TWI239830B (en) 2005-09-21
DE10046514A1 (de) 2002-04-25
EP1317208A1 (de) 2003-06-11
AU2002212207A1 (en) 2002-03-26
JP2004508123A (ja) 2004-03-18
NO20031204D0 (no) 2003-03-17
WO2002022011A1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
NO20030860L (no) Tioflavinderivater for anvendelse i antemortemdiagnose av Alzheimers sykdom og in vivo-avbildning og hindring av amyloid avsetning
DK0907379T3 (da) Bioaktiveret diagnostisk billeddannelseskontrastmiddel
EP1421897A4 (de) Vorrichtung zur untersuchung von blutgefässerkrankungen und bypass-diagnosevorrichtung für blutgefässe
NO20002380D0 (no) Forbindelser for før-døden diagnose av Alzheimers sykdom og in vivo billeddannelse, samt forhindring av amyloid deponering
FI990559A (fi) Näytteenkäsittelymenetelmä ja diagnostinen mittauslaite
ITSV980052A0 (it) Lettino porta paziente o simili, e macchina, in particolare per il rilevamento d'immagini in risonanza magnetica nucleare in conbinazione
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
DE69535509D1 (de) Medizinische diagnostische Bilddarstellungssystem und Verfahren
RU2007131930A (ru) Лечение и диагностика заболеваний, опосредованных макрофагами
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
EE200300005A (et) Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
NO991688L (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
NO940711D0 (no) Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
NO20016427D0 (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
DE69837968D1 (de) Diagnose und behandlung myocardieller fehler
DE19983769T1 (de) Ultraschallverfahren zur Medizinischen diagnose und System zur Elementumschaltung
DE69727998D1 (de) Optimaler Diagnosepunktdetektor für nichtinvasive Diagnose von Blutbestandteile
NO971348D0 (no) Pröveenhet for oppsamling og undersökelse av kroppsvæske
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
NO20032007D0 (no) Radiofarmasöytiske midler for diagnose av Alzheimer's sykdom
NO20002517L (no) Magnetisk resonansavbildningsmidler for deteksjon av fysiologiske midler
IL130939A0 (en) Probe devices particularly useful for non-invasive detection of medical conditions
NO20031204L (no) Fremgangsmate for billedmessig presentasjon og diagnose av tromber ved hjelp av kjernespinntomografi under anvendelse av partikulaere kontrastmidler
NO940115D0 (no) Kontrastmidler for roentgen- og magnettomografisk avbildning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application